62279 Remibrutinib in patients with moderate to severe hidradenitis suppurativa: Patient reported outcomes from a randomized, phase 2, double-blind, placebo-controlled platform study

作者：Alexa B. Kimball, Errol P. Prens, Falk G. Bechara, Jóhann E. Guðjónsson, B K Bang, Swati Ghanshani, Christian Loesche · 发表于：Journal of the American Academy of Dermatology · 年份：2025 · DOI：10.1016/j.jaad.2025.05.1142 · 被引用次数：3 · 研究领域：Hidradenitis Suppurativa and Treatments、Colorectal and Anal Carcinomas、Chemotherapy-related skin toxicity